Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Foundation Healthcare, Inc. (FDNH)
|
Add to portfolio |
|
|
|
| Price: |
$0.06
| | Metrics |
| OS: |
18.1
|
M
| |
|
|
| Market cap: |
$1.08
|
M
| |
-12
|
% ROIC
|
|
Net debt:
|
$45.6
|
M
| |
24.8
|
x Debt/EBITDA
|
|
EV:
|
$46.7
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$1.8
|
M
| |
25.4
|
x EV/EBITDA
|
|
EBIT
|
($6.5)
|
M
| |
|
|
| EPS |
($0.69)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| Revenues | 126.1 | 101.9 | 87.2 | 53.0 | 17.5 | 20.5 | 17.6 | 96.6 |
| Revenue growth | 23.8% | 16.8% | 64.6% | 202.5% | -14.7% | 16.8% | -81.8% | 92.0% |
| Cost of goods sold | 33.9 | 29.3 | 28.3 | 15.7 | 6.9 | 7.1 | 5.5 | 67.8 |
| Gross profit | 92.3 | 72.6 | 58.9 | 37.3 | 10.6 | 13.4 | 12.0 | 28.8 |
| Gross margin | 73.1% | 71.3% | 67.6% | 70.4% | 60.7% | 65.2% | 68.6% | 29.8% |
| Selling, general and administrative | | | | | 13.7 | 15.8 | 13.6 | 23.8 |
| General and administrative | 27.8 | 24.0 | 22.9 | 11.1 | | | | |
| EBITA | 8.3 | 4.7 | 15.3 | 5.5 | -5.0 | -13.6 | -6.4 | 0.6 |
| EBITA margin | 6.6% | 4.6% | 17.6% | 10.5% | -28.4% | -66.3% | -36.4% | 0.6% |
| Amortization of intangibles | 2.1 | 2.1 | 1.9 | 0.8 | 0.1 | | | |
| EBIT | 6.3 | 2.6 | 13.4 | 4.8 | -5.1 | -13.6 | -6.4 | 0.6 |
| EBIT margin | 5.0% | 2.6% | 15.4% | 9.0% | -29.2% | -66.3% | -36.4% | 0.6% |
| Pre-tax income | 5.2 | 1.4 | -10.4 | 3.8 | -6.4 | -15.6 | -7.3 | 1.4 |
| Income taxes | -1.1 | -0.9 | 3.8 | 0.0 | 0.0 | 0.1 | 0.0 | -0.1 |
| Tax rate | | | | 1.2% | | | 0.0% | |
| Earnings from continuing ops | -1.0 | -2.3 | -19.6 | 2.5 | -12.6 | -15.6 | -7.3 | 0.7 |
| Earnings from discontinued ops | 6.2 | 0.3 | -0.8 | | 0.3 | -3.6 | -5.2 | 0.1 |
| Net income | 5.2 | -2.1 | -20.4 | 2.5 | -12.3 | -19.1 | -5.3 | 0.7 |
| Net margin | 4.1% | -2.1% | -23.4% | 4.6% | -70.3% | -93.2% | -30.4% | 0.8% |
| |
| Diluted EPS | ($0.06) | ($0.14) | ($1.44) | $0.02 | ($1.09) | ($2.15) | ($0.26) | $0.03 |
| Shares outstanding (diluted) | 17.3 | 17.1 | 13.6 | 162.5 | 11.5 | 7.2 | 28.4 | 26.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|